Trial Outcomes & Findings for TRANSLATE: Transgender and Gender Nonconforming Individuals' Access to Healthcare (NCT NCT03808883)
NCT ID: NCT03808883
Last Updated: 2024-08-14
Results Overview
TGNC participants were asked pre and post-intervention to name all the hospitals they knew of where they could received medical care. Mean and range are reported. This measure was unreliable as participants, when asked in the post survey to name locations for healthcare, were not given those they had identified in the pre-intervention survey, so some participants actually decreased the number they named. Additionally, growth from this measure is mean growth of the group, not a mean of the sum of individual's growth.
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
49 participants
Primary outcome timeframe
Baseline and 11 months
Results posted on
2024-08-14
Participant Flow
Participant milestones
| Measure |
TGNC Cohort
Transgender and gender non-conforming (TGNC) identifying individuals.
TGNC Directed Advocacy Meetings: Series of 18 community meetings with TGNC individuals, 3 of which were facilitated dialogues with health professionals to articulate barriers to access and to enter into dialogue with medical providers and staff.
|
Healthcare Participants
Healthcare Providers and staff who participated in a facilitated dialogue with the TGNC Cohort. The Translate Study held three facilitated dialogue sessions with both the TGNC Cohort and Healthcare Participants, identified as physicians, nurse practitioners, registered nurses, students, physician assistants, and non-provider staff positions. Each Healthcare Participant only attended one of the three sessions.
|
|---|---|---|
|
Overall Study
STARTED
|
20
|
29
|
|
Overall Study
COMPLETED
|
14
|
26
|
|
Overall Study
NOT COMPLETED
|
6
|
3
|
Reasons for withdrawal
| Measure |
TGNC Cohort
Transgender and gender non-conforming (TGNC) identifying individuals.
TGNC Directed Advocacy Meetings: Series of 18 community meetings with TGNC individuals, 3 of which were facilitated dialogues with health professionals to articulate barriers to access and to enter into dialogue with medical providers and staff.
|
Healthcare Participants
Healthcare Providers and staff who participated in a facilitated dialogue with the TGNC Cohort. The Translate Study held three facilitated dialogue sessions with both the TGNC Cohort and Healthcare Participants, identified as physicians, nurse practitioners, registered nurses, students, physician assistants, and non-provider staff positions. Each Healthcare Participant only attended one of the three sessions.
|
|---|---|---|
|
Overall Study
Withdrawal by Subject
|
2
|
0
|
|
Overall Study
Did not complete pre test or post test survey
|
4
|
3
|
Baseline Characteristics
Only TGNC participants were asked this question.
Baseline characteristics by cohort
| Measure |
TGNC Cohort
n=20 Participants
Transgender and gender non-conforming (TGNC) identifying individuals.
TGNC Directed Advocacy Meetings: Series of 18 community meetings with TGNC individuals, 3 of which were facilitated dialogues with health professionals to articulate barriers to access and to enter into dialogue with medical providers and staff.
|
Healthcare Participants
n=29 Participants
Healthcare Providers and staff who participated in a facilitated dialogue with the TGNC Cohort. The Translate Study held three facilitated dialogue sessions with both the TGNC Cohort and Healthcare Participants, identified as physicians, nurse practitioners, registered nurses, students, physician assistants, and non-provider staff positions. Each Healthcare Participant only attended one of the three sessions.
|
Total
n=49 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
27.82 years
n=20 Participants
|
37.65 years
n=29 Participants
|
32.74 years
n=49 Participants
|
|
Sex/Gender, Customized
Transwoman/female
|
10 Participants
n=20 Participants
|
24 Participants
n=29 Participants
|
34 Participants
n=49 Participants
|
|
Sex/Gender, Customized
Transmen/male
|
6 Participants
n=20 Participants
|
3 Participants
n=29 Participants
|
9 Participants
n=49 Participants
|
|
Sex/Gender, Customized
Non-binary/unlabeled
|
4 Participants
n=20 Participants
|
2 Participants
n=29 Participants
|
6 Participants
n=49 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
1 Participants
n=20 Participants
|
0 Participants
n=29 Participants
|
1 Participants
n=49 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
19 Participants
n=20 Participants
|
29 Participants
n=29 Participants
|
48 Participants
n=49 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=20 Participants
|
0 Participants
n=29 Participants
|
0 Participants
n=49 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=20 Participants
|
0 Participants
n=29 Participants
|
0 Participants
n=49 Participants
|
|
Race (NIH/OMB)
Asian
|
2 Participants
n=20 Participants
|
3 Participants
n=29 Participants
|
5 Participants
n=49 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=20 Participants
|
0 Participants
n=29 Participants
|
0 Participants
n=49 Participants
|
|
Race (NIH/OMB)
Black or African American
|
6 Participants
n=20 Participants
|
1 Participants
n=29 Participants
|
7 Participants
n=49 Participants
|
|
Race (NIH/OMB)
White
|
10 Participants
n=20 Participants
|
22 Participants
n=29 Participants
|
32 Participants
n=49 Participants
|
|
Race (NIH/OMB)
More than one race
|
2 Participants
n=20 Participants
|
3 Participants
n=29 Participants
|
5 Participants
n=49 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=20 Participants
|
0 Participants
n=29 Participants
|
0 Participants
n=49 Participants
|
|
Region of Enrollment
United States
|
20 Participants
n=20 Participants
|
29 Participants
n=29 Participants
|
49 Participants
n=49 Participants
|
|
Total Number of Locations to Receive Medical Care Known by TGNC participants
|
3.36 locations
n=14 Participants • Only TGNC participants were asked this question.
|
—
|
3.35 locations
n=14 Participants • Only TGNC participants were asked this question.
|
|
Knowledge of transgender and gender nonconforming medical issues
Strongly Disagree
|
0 Participants
n=20 Participants
|
0 Participants
n=29 Participants
|
0 Participants
n=49 Participants
|
|
Knowledge of transgender and gender nonconforming medical issues
Disagree
|
4 Participants
n=20 Participants
|
7 Participants
n=29 Participants
|
11 Participants
n=49 Participants
|
|
Knowledge of transgender and gender nonconforming medical issues
Neutral
|
1 Participants
n=20 Participants
|
4 Participants
n=29 Participants
|
5 Participants
n=49 Participants
|
|
Knowledge of transgender and gender nonconforming medical issues
Agree
|
7 Participants
n=20 Participants
|
11 Participants
n=29 Participants
|
18 Participants
n=49 Participants
|
|
Knowledge of transgender and gender nonconforming medical issues
Strongly Agree
|
7 Participants
n=20 Participants
|
4 Participants
n=29 Participants
|
11 Participants
n=49 Participants
|
|
Knowledge of transgender and gender nonconforming medical issues
No response
|
1 Participants
n=20 Participants
|
3 Participants
n=29 Participants
|
4 Participants
n=49 Participants
|
|
Ability to Navigate Healthcare System
Strongly Disagree
|
0 Participants
n=20 Participants • This question was only applicable to TGNC participants.
|
—
|
0 Participants
n=20 Participants • This question was only applicable to TGNC participants.
|
|
Ability to Navigate Healthcare System
Disagree
|
4 Participants
n=20 Participants • This question was only applicable to TGNC participants.
|
—
|
4 Participants
n=20 Participants • This question was only applicable to TGNC participants.
|
|
Ability to Navigate Healthcare System
Neutral
|
6 Participants
n=20 Participants • This question was only applicable to TGNC participants.
|
—
|
6 Participants
n=20 Participants • This question was only applicable to TGNC participants.
|
|
Ability to Navigate Healthcare System
Agree
|
5 Participants
n=20 Participants • This question was only applicable to TGNC participants.
|
—
|
5 Participants
n=20 Participants • This question was only applicable to TGNC participants.
|
|
Ability to Navigate Healthcare System
Strongly Agree
|
3 Participants
n=20 Participants • This question was only applicable to TGNC participants.
|
—
|
3 Participants
n=20 Participants • This question was only applicable to TGNC participants.
|
|
Ability to Navigate Healthcare System
No response
|
2 Participants
n=20 Participants • This question was only applicable to TGNC participants.
|
—
|
2 Participants
n=20 Participants • This question was only applicable to TGNC participants.
|
|
Knowledge of How to Express Health and Well-being Concerns
Disagree Strongly
|
0 Participants
n=20 Participants • This question was only applicable to TGNC participants.
|
—
|
0 Participants
n=20 Participants • This question was only applicable to TGNC participants.
|
|
Knowledge of How to Express Health and Well-being Concerns
Disagree
|
2 Participants
n=20 Participants • This question was only applicable to TGNC participants.
|
—
|
2 Participants
n=20 Participants • This question was only applicable to TGNC participants.
|
|
Knowledge of How to Express Health and Well-being Concerns
Neutral
|
3 Participants
n=20 Participants • This question was only applicable to TGNC participants.
|
—
|
3 Participants
n=20 Participants • This question was only applicable to TGNC participants.
|
|
Knowledge of How to Express Health and Well-being Concerns
Agree
|
8 Participants
n=20 Participants • This question was only applicable to TGNC participants.
|
—
|
8 Participants
n=20 Participants • This question was only applicable to TGNC participants.
|
|
Knowledge of How to Express Health and Well-being Concerns
Agree Strongly
|
6 Participants
n=20 Participants • This question was only applicable to TGNC participants.
|
—
|
6 Participants
n=20 Participants • This question was only applicable to TGNC participants.
|
|
Knowledge of How to Express Health and Well-being Concerns
No Response
|
1 Participants
n=20 Participants • This question was only applicable to TGNC participants.
|
—
|
1 Participants
n=20 Participants • This question was only applicable to TGNC participants.
|
|
Comfort in Advocating for Respectful and Appropriate Healthcare
Disagree Strongly
|
—
|
0 Participants
n=29 Participants • The question was only applicable to Healthcare participants.
|
0 Participants
n=29 Participants • The question was only applicable to Healthcare participants.
|
|
Comfort in Advocating for Respectful and Appropriate Healthcare
Disagree
|
—
|
2 Participants
n=29 Participants • The question was only applicable to Healthcare participants.
|
2 Participants
n=29 Participants • The question was only applicable to Healthcare participants.
|
|
Comfort in Advocating for Respectful and Appropriate Healthcare
Neutral
|
—
|
6 Participants
n=29 Participants • The question was only applicable to Healthcare participants.
|
6 Participants
n=29 Participants • The question was only applicable to Healthcare participants.
|
|
Comfort in Advocating for Respectful and Appropriate Healthcare
Agree
|
—
|
10 Participants
n=29 Participants • The question was only applicable to Healthcare participants.
|
10 Participants
n=29 Participants • The question was only applicable to Healthcare participants.
|
|
Comfort in Advocating for Respectful and Appropriate Healthcare
Agree Strongly
|
—
|
11 Participants
n=29 Participants • The question was only applicable to Healthcare participants.
|
11 Participants
n=29 Participants • The question was only applicable to Healthcare participants.
|
|
Comfort in Advocating for Respectful and Appropriate Healthcare
No Response
|
—
|
0 Participants
n=29 Participants • The question was only applicable to Healthcare participants.
|
0 Participants
n=29 Participants • The question was only applicable to Healthcare participants.
|
PRIMARY outcome
Timeframe: Baseline and 11 monthsPopulation: Only TGNC participants who completed pre and post intervention surveys were included.
TGNC participants were asked pre and post-intervention to name all the hospitals they knew of where they could received medical care. Mean and range are reported. This measure was unreliable as participants, when asked in the post survey to name locations for healthcare, were not given those they had identified in the pre-intervention survey, so some participants actually decreased the number they named. Additionally, growth from this measure is mean growth of the group, not a mean of the sum of individual's growth.
Outcome measures
| Measure |
TGNC Cohort
n=14 Participants
The Translate Study developed a cohort of transgender and gender non-conforming individuals (referred to here as TGNC cohort) and held three facilitated dialogue sessions with healthcare providers and staff (referred to here as healthcare participants). The overall goal of the Translate Study was to improve quality of life by reducing health disparities suffered by transgender and gender nonconforming (TGNC) individuals and by increasing their access to and use of primary health care.
TGNC Directed Advocacy Meetings: Series of 18 meetings with TGNC cohort, including 3 facilitated dialogues with the healthcare participants, to articulate barriers to access and to enter into dialogue with medical providers and staff.
Facilitated Dialogues between TGNC Cohort and Healthcare Participants: Healthcare Participants attend a facilitated dialogue with the TGNC cohort. 3 total facilitated dialogues were held, but each healthcare participant attends only 1 session.
|
Healthcare Participants
The Translate Study held three facilitated dialogue sessions between the TGNC Cohort and a group of healthcare participants, identified as physicians, nurse practitioners, registered nurses, students, physician assistants, and non-provider staff positions. Non-providers included healthcare administrative positions, rehabilitation, and vocational services.
Facilitated Dialogues between TGNC Cohort and Healthcare Participants: Healthcare Participants attend a facilitated dialogue with the TGNC cohort. 3 total facilitated dialogues were held, but each healthcare participant attends only 1 session.
|
|---|---|---|
|
Change in Knowledge of TGNC Individuals of Total Number of Locations to Receive Medical Care in Cleveland Known
|
3.79 locations
Interval 1.0 to 13.0
|
—
|
PRIMARY outcome
Timeframe: Baseline and 11 monthsPopulation: Both the TGNC Cohort and the Healthcare Participant change from baseline in knowledge was measured using the similar question and same scale. TGNC cohort measurement occurred at the first and last date of the TGNC led advocacy meetings (baseline and 11 months later) and the Healthcare Participants measurement occurred at the start and end of their facilitated dialogue with the TGNC Cohort (one 2 hour intervention).
TGNC Cohort Participants were asked to respond with their agreement with the following statement: "I am knowledgeable about how being transgender or gender non-conforming impacts my health." Response options were 1=Disagree Strongly, 2=Disagree, 3=Neutral, 4=Agree, and 5=Agree Strongly. Change was measured as month 11 minus baseline score, and higher scores represented the better outcome.
Outcome measures
| Measure |
TGNC Cohort
n=14 Participants
The Translate Study developed a cohort of transgender and gender non-conforming individuals (referred to here as TGNC cohort) and held three facilitated dialogue sessions with healthcare providers and staff (referred to here as healthcare participants). The overall goal of the Translate Study was to improve quality of life by reducing health disparities suffered by transgender and gender nonconforming (TGNC) individuals and by increasing their access to and use of primary health care.
TGNC Directed Advocacy Meetings: Series of 18 meetings with TGNC cohort, including 3 facilitated dialogues with the healthcare participants, to articulate barriers to access and to enter into dialogue with medical providers and staff.
Facilitated Dialogues between TGNC Cohort and Healthcare Participants: Healthcare Participants attend a facilitated dialogue with the TGNC cohort. 3 total facilitated dialogues were held, but each healthcare participant attends only 1 session.
|
Healthcare Participants
The Translate Study held three facilitated dialogue sessions between the TGNC Cohort and a group of healthcare participants, identified as physicians, nurse practitioners, registered nurses, students, physician assistants, and non-provider staff positions. Non-providers included healthcare administrative positions, rehabilitation, and vocational services.
Facilitated Dialogues between TGNC Cohort and Healthcare Participants: Healthcare Participants attend a facilitated dialogue with the TGNC cohort. 3 total facilitated dialogues were held, but each healthcare participant attends only 1 session.
|
|---|---|---|
|
Change From Baseline in Knowledge of TGNC Cohort About Transgender and Gender Nonconforming Medical Issues
Disagree Strongly
|
1 Participants
|
0 Participants
|
|
Change From Baseline in Knowledge of TGNC Cohort About Transgender and Gender Nonconforming Medical Issues
Disagree
|
1 Participants
|
0 Participants
|
|
Change From Baseline in Knowledge of TGNC Cohort About Transgender and Gender Nonconforming Medical Issues
Neutral
|
6 Participants
|
0 Participants
|
|
Change From Baseline in Knowledge of TGNC Cohort About Transgender and Gender Nonconforming Medical Issues
Agree
|
2 Participants
|
0 Participants
|
|
Change From Baseline in Knowledge of TGNC Cohort About Transgender and Gender Nonconforming Medical Issues
Agree Strongly
|
4 Participants
|
0 Participants
|
PRIMARY outcome
Timeframe: Baseline and 24 hoursPopulation: The Healthcare Participants measurement occurred at the start and within 24 hours after the end of their facilitated dialogue with the TGNC Cohort (one 2 hour intervention).
Healthcare Participants were asked to respond with their agreement with the following statement: "I know about medical issues that affect transgender and gender nonconforming patients." Response options were 1=Disagree Strongly, 2=Disagree, 3=Neutral, 4=Agree, and 5=Agree Strongly. Because healthcare providers only participated in one facilitated dialogue, baseline was measured prior to the dialogue, and post measures were administered the day after the dialogue. Change was measured as post score- baseline score, and higher scores represented the better outcome.
Outcome measures
| Measure |
TGNC Cohort
The Translate Study developed a cohort of transgender and gender non-conforming individuals (referred to here as TGNC cohort) and held three facilitated dialogue sessions with healthcare providers and staff (referred to here as healthcare participants). The overall goal of the Translate Study was to improve quality of life by reducing health disparities suffered by transgender and gender nonconforming (TGNC) individuals and by increasing their access to and use of primary health care.
TGNC Directed Advocacy Meetings: Series of 18 meetings with TGNC cohort, including 3 facilitated dialogues with the healthcare participants, to articulate barriers to access and to enter into dialogue with medical providers and staff.
Facilitated Dialogues between TGNC Cohort and Healthcare Participants: Healthcare Participants attend a facilitated dialogue with the TGNC cohort. 3 total facilitated dialogues were held, but each healthcare participant attends only 1 session.
|
Healthcare Participants
n=26 Participants
The Translate Study held three facilitated dialogue sessions between the TGNC Cohort and a group of healthcare participants, identified as physicians, nurse practitioners, registered nurses, students, physician assistants, and non-provider staff positions. Non-providers included healthcare administrative positions, rehabilitation, and vocational services.
Facilitated Dialogues between TGNC Cohort and Healthcare Participants: Healthcare Participants attend a facilitated dialogue with the TGNC cohort. 3 total facilitated dialogues were held, but each healthcare participant attends only 1 session.
|
|---|---|---|
|
Change From Baseline in Knowledge of Healthcare Participants About Transgender and Gender Nonconforming Medical Issues
Disagree
|
0 Participants
|
2 Participants
|
|
Change From Baseline in Knowledge of Healthcare Participants About Transgender and Gender Nonconforming Medical Issues
Disagree Strongly
|
0 Participants
|
0 Participants
|
|
Change From Baseline in Knowledge of Healthcare Participants About Transgender and Gender Nonconforming Medical Issues
Neutral
|
0 Participants
|
3 Participants
|
|
Change From Baseline in Knowledge of Healthcare Participants About Transgender and Gender Nonconforming Medical Issues
Agree
|
0 Participants
|
15 Participants
|
|
Change From Baseline in Knowledge of Healthcare Participants About Transgender and Gender Nonconforming Medical Issues
Agree Strongly
|
0 Participants
|
6 Participants
|
PRIMARY outcome
Timeframe: Baseline and 11 monthsPopulation: Only the TGNC (n=14) were asked these questions at baseline (pre-intervention) and 11 months (post-intervention).
TGNC Individuals were asked to respond with their agreement with the following two statements: 1. "I am able to navigate the healthcare system easily", and 2. "I know how to express my concerns about my health and well-being to healthcare providers." Response options were 1=Disagree Strongly, 2-=Disagree, 3=Neutral, 4=Agree and 5=Strongly agree. For these questions, a higher score indicated confident attitude in handling their healthcare needs. Change from Baseline to 11 months was measured.
Outcome measures
| Measure |
TGNC Cohort
n=14 Participants
The Translate Study developed a cohort of transgender and gender non-conforming individuals (referred to here as TGNC cohort) and held three facilitated dialogue sessions with healthcare providers and staff (referred to here as healthcare participants). The overall goal of the Translate Study was to improve quality of life by reducing health disparities suffered by transgender and gender nonconforming (TGNC) individuals and by increasing their access to and use of primary health care.
TGNC Directed Advocacy Meetings: Series of 18 meetings with TGNC cohort, including 3 facilitated dialogues with the healthcare participants, to articulate barriers to access and to enter into dialogue with medical providers and staff.
Facilitated Dialogues between TGNC Cohort and Healthcare Participants: Healthcare Participants attend a facilitated dialogue with the TGNC cohort. 3 total facilitated dialogues were held, but each healthcare participant attends only 1 session.
|
Healthcare Participants
The Translate Study held three facilitated dialogue sessions between the TGNC Cohort and a group of healthcare participants, identified as physicians, nurse practitioners, registered nurses, students, physician assistants, and non-provider staff positions. Non-providers included healthcare administrative positions, rehabilitation, and vocational services.
Facilitated Dialogues between TGNC Cohort and Healthcare Participants: Healthcare Participants attend a facilitated dialogue with the TGNC cohort. 3 total facilitated dialogues were held, but each healthcare participant attends only 1 session.
|
|---|---|---|
|
Change From Baseline in Attitude of TGNC Individuals Towards Navigating Their Interactions With Healthcare Providers.
I am able to navigate the healthcare system easily · Neutral
|
1 Participants
|
—
|
|
Change From Baseline in Attitude of TGNC Individuals Towards Navigating Their Interactions With Healthcare Providers.
I know how to express my concerns about my health and well-being to healthcare providers. · Agree Strongly
|
6 Participants
|
—
|
|
Change From Baseline in Attitude of TGNC Individuals Towards Navigating Their Interactions With Healthcare Providers.
I know how to express my concerns about my health and well-being to healthcare providers. · No response
|
0 Participants
|
—
|
|
Change From Baseline in Attitude of TGNC Individuals Towards Navigating Their Interactions With Healthcare Providers.
I am able to navigate the healthcare system easily · Disagree Strongly
|
0 Participants
|
—
|
|
Change From Baseline in Attitude of TGNC Individuals Towards Navigating Their Interactions With Healthcare Providers.
I am able to navigate the healthcare system easily · Disagree
|
3 Participants
|
—
|
|
Change From Baseline in Attitude of TGNC Individuals Towards Navigating Their Interactions With Healthcare Providers.
I am able to navigate the healthcare system easily · Agree
|
6 Participants
|
—
|
|
Change From Baseline in Attitude of TGNC Individuals Towards Navigating Their Interactions With Healthcare Providers.
I am able to navigate the healthcare system easily · Agree Strongly
|
4 Participants
|
—
|
|
Change From Baseline in Attitude of TGNC Individuals Towards Navigating Their Interactions With Healthcare Providers.
I am able to navigate the healthcare system easily · No response
|
0 Participants
|
—
|
|
Change From Baseline in Attitude of TGNC Individuals Towards Navigating Their Interactions With Healthcare Providers.
I know how to express my concerns about my health and well-being to healthcare providers. · Disagree Strongly
|
0 Participants
|
—
|
|
Change From Baseline in Attitude of TGNC Individuals Towards Navigating Their Interactions With Healthcare Providers.
I know how to express my concerns about my health and well-being to healthcare providers. · Disagree
|
1 Participants
|
—
|
|
Change From Baseline in Attitude of TGNC Individuals Towards Navigating Their Interactions With Healthcare Providers.
I know how to express my concerns about my health and well-being to healthcare providers. · Neutral
|
5 Participants
|
—
|
|
Change From Baseline in Attitude of TGNC Individuals Towards Navigating Their Interactions With Healthcare Providers.
I know how to express my concerns about my health and well-being to healthcare providers. · Agree
|
2 Participants
|
—
|
PRIMARY outcome
Timeframe: Baseline and 24 hours.Population: Only Healthcare Participants were asked this question.
Healthcare Participants were asked to respond with their agreement with the following statement: "I am comfortable advocating for transgender and gender non-conforming people's right to access respectful and appropriate health care in the place where I practice." Response Options were 1=Disagree Strongly, 2=Disagree, 3=Neutral, 4=Agree, and 5=Agree Strongly, with a higher score indicating a more positive attitude towards transgender issues. Change was measured by subtracting the providers' responses after participation in a facilitated dialogue with TGNC participants from their scored response prior to participating in the dialogue.
Outcome measures
| Measure |
TGNC Cohort
The Translate Study developed a cohort of transgender and gender non-conforming individuals (referred to here as TGNC cohort) and held three facilitated dialogue sessions with healthcare providers and staff (referred to here as healthcare participants). The overall goal of the Translate Study was to improve quality of life by reducing health disparities suffered by transgender and gender nonconforming (TGNC) individuals and by increasing their access to and use of primary health care.
TGNC Directed Advocacy Meetings: Series of 18 meetings with TGNC cohort, including 3 facilitated dialogues with the healthcare participants, to articulate barriers to access and to enter into dialogue with medical providers and staff.
Facilitated Dialogues between TGNC Cohort and Healthcare Participants: Healthcare Participants attend a facilitated dialogue with the TGNC cohort. 3 total facilitated dialogues were held, but each healthcare participant attends only 1 session.
|
Healthcare Participants
n=26 Participants
The Translate Study held three facilitated dialogue sessions between the TGNC Cohort and a group of healthcare participants, identified as physicians, nurse practitioners, registered nurses, students, physician assistants, and non-provider staff positions. Non-providers included healthcare administrative positions, rehabilitation, and vocational services.
Facilitated Dialogues between TGNC Cohort and Healthcare Participants: Healthcare Participants attend a facilitated dialogue with the TGNC cohort. 3 total facilitated dialogues were held, but each healthcare participant attends only 1 session.
|
|---|---|---|
|
Change in Attitude of Medical Providers Towards Transgender Issues.
Disagree Strongly
|
—
|
0 Participants
|
|
Change in Attitude of Medical Providers Towards Transgender Issues.
Disagree
|
—
|
1 Participants
|
|
Change in Attitude of Medical Providers Towards Transgender Issues.
Neutral
|
—
|
1 Participants
|
|
Change in Attitude of Medical Providers Towards Transgender Issues.
Agree
|
—
|
10 Participants
|
|
Change in Attitude of Medical Providers Towards Transgender Issues.
Agree Strongly
|
—
|
14 Participants
|
|
Change in Attitude of Medical Providers Towards Transgender Issues.
No response
|
—
|
0 Participants
|
PRIMARY outcome
Timeframe: Interview at 11 months.Population: Amongst the 8 TGNC participants who agreed to be interviewed following the intervention, a key theme in the qualitative evaluation was a sense of personal growth in confidence regarding speaking up both inside and outside of healthcare settings.
Percentage of TGNC individuals expressing key themes related to shift of confidence of TGNC Individuals to seek medical care following the intervention.
Outcome measures
| Measure |
TGNC Cohort
n=8 Participants
The Translate Study developed a cohort of transgender and gender non-conforming individuals (referred to here as TGNC cohort) and held three facilitated dialogue sessions with healthcare providers and staff (referred to here as healthcare participants). The overall goal of the Translate Study was to improve quality of life by reducing health disparities suffered by transgender and gender nonconforming (TGNC) individuals and by increasing their access to and use of primary health care.
TGNC Directed Advocacy Meetings: Series of 18 meetings with TGNC cohort, including 3 facilitated dialogues with the healthcare participants, to articulate barriers to access and to enter into dialogue with medical providers and staff.
Facilitated Dialogues between TGNC Cohort and Healthcare Participants: Healthcare Participants attend a facilitated dialogue with the TGNC cohort. 3 total facilitated dialogues were held, but each healthcare participant attends only 1 session.
|
Healthcare Participants
The Translate Study held three facilitated dialogue sessions between the TGNC Cohort and a group of healthcare participants, identified as physicians, nurse practitioners, registered nurses, students, physician assistants, and non-provider staff positions. Non-providers included healthcare administrative positions, rehabilitation, and vocational services.
Facilitated Dialogues between TGNC Cohort and Healthcare Participants: Healthcare Participants attend a facilitated dialogue with the TGNC cohort. 3 total facilitated dialogues were held, but each healthcare participant attends only 1 session.
|
|---|---|---|
|
Qualitative Shift in Confidence of TGNC Individuals in Seeking Medical Care After the Intervention.
|
8 Participants
|
0 Participants
|
PRIMARY outcome
Timeframe: Interview within one day following the facilitated dialoguePopulation: This was a qualitative interview and analysis was for only the 8 healthcare participants who agreed to the structured interviews following the intervention in structured interviews.
The number of medical providers expressing themes illustrating a shift in confidence with their ability to provide culturally competent medical care in structured interview following the facilitated dialogue with members of the TGNC participant group.
Outcome measures
| Measure |
TGNC Cohort
n=8 Participants
The Translate Study developed a cohort of transgender and gender non-conforming individuals (referred to here as TGNC cohort) and held three facilitated dialogue sessions with healthcare providers and staff (referred to here as healthcare participants). The overall goal of the Translate Study was to improve quality of life by reducing health disparities suffered by transgender and gender nonconforming (TGNC) individuals and by increasing their access to and use of primary health care.
TGNC Directed Advocacy Meetings: Series of 18 meetings with TGNC cohort, including 3 facilitated dialogues with the healthcare participants, to articulate barriers to access and to enter into dialogue with medical providers and staff.
Facilitated Dialogues between TGNC Cohort and Healthcare Participants: Healthcare Participants attend a facilitated dialogue with the TGNC cohort. 3 total facilitated dialogues were held, but each healthcare participant attends only 1 session.
|
Healthcare Participants
The Translate Study held three facilitated dialogue sessions between the TGNC Cohort and a group of healthcare participants, identified as physicians, nurse practitioners, registered nurses, students, physician assistants, and non-provider staff positions. Non-providers included healthcare administrative positions, rehabilitation, and vocational services.
Facilitated Dialogues between TGNC Cohort and Healthcare Participants: Healthcare Participants attend a facilitated dialogue with the TGNC cohort. 3 total facilitated dialogues were held, but each healthcare participant attends only 1 session.
|
|---|---|---|
|
Qualitative Shift in Confidence of Medical Provider in Providing Culturally Competent Medical Care to TGNC Individuals After the Intervention.
Expressing confidence in structured interview
|
6 percentage of hc participants
|
—
|
|
Qualitative Shift in Confidence of Medical Provider in Providing Culturally Competent Medical Care to TGNC Individuals After the Intervention.
Expressing no confidence in structured interview
|
2 percentage of hc participants
|
—
|
Adverse Events
TGNC Cohort
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Healthcare Participants
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Sarah Fulton, MA, RA, Begun Center, Jack, Joseph and Morton Mandel School of Applied Social Science
Case Western Reserve University
Phone: 216-368-0429
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place